As with the LRRK2 G2019S+ /R1441G+ PD groups, the GBA1 N409S+ PD had significantly longer disease duration and associated higher MDS-UPDRS III Off and lower MoCA scores when compared to sPD. This evidence concerns the gene LRRK2 and Parkinson disease.